Search
Search Results
##search.searchResults.foundPlural##
-
-
TYROSINE KINASE INHIBITORS AND INTERFERON
2807PDF: 1393HTML: 3038Cover Letter: 185 -
-
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2341PDF: 974HTML: 1630Fig 1: 167Tab I: 193Cover Letter: 185 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1965PDF: 782HTML: 196 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1548PDF: 1041HTML: 100 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2407PDF: 761HTML: 1721 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4306PDF: 878HTML: 1300Table1: 166 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1356PDF: 713Suppl. Files: 299Html: 122 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1651PDF: 782HTML: 922cover letter: 251 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1343PDF: 798HTML: 3104 -
Acquired Hemophilia A successfully treated with rituximab
1859PDF: 1099HTML: 1443Figure 1: 153 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1035PDF: 528HTML: 1676Figures: 150Fifures Sanz: 161tables Sanz: 165Untitled: 160 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1308HTML: 370PDF: 794 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1537PDF: 778HTML: 139 -
WHAT ARE FUNGAL INFECTIONS?
4054PDF: 2314HTML: 27551de Pauw: 221 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4009PDF: 1540HTML: 847 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2178PDF: 1006HTML: 1972Characteristic of study group: 179 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1173PDF: 573HTML: 202 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3969PDF: 1896HTML: 5193Table 1: 169 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1374PDF: 730HTML: 192 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3166PDF: 1684HTML: 1071 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2087PDF: 1299HTML: 3487 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1707PDF: 546HTML: 263 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6704PDF: 3572HTML: 725 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1247PDF: 539Suppl. Files: 329HTML: 129







